## **Core Concept**
The question tests the knowledge of B cell markers, which are specific antigens expressed on the surface of B cells at various stages of their development and maturation. These markers are crucial for the identification and classification of B cell malignancies and for understanding B cell development.

## **Why the Correct Answer is Right**
CD19 is a B cell marker expressed from the early stages of B cell development (pro-B cell) until maturity, but it is lost during the terminal differentiation into plasma cells. CD20 is another marker present on mature B cells but is not expressed on the early pro-B cell stage or on plasma cells. CD21 (CR2) and CD23 are also markers associated with mature B cells. However, **CD10** (also known as common acute lymphoblastic leukemia antigen or CALLA) is a marker that can be expressed on early lymphoid progenitors, not exclusively a B cell marker across all stages, and is notably expressed on precursor B cells (pre-B cells) and germinal center B cells.

## **Why Each Wrong Option is Incorrect**
- **Option A: CD19** - This is a specific B cell marker expressed from early B cell development to maturity, excluding plasma cells.
- **Option B: CD20** - This is a marker for mature B cells and is not expressed on early pro-B cells or plasma cells, making it B cell specific but not across all B cell developmental stages.
- **Option D: CD21** - This is a marker for mature B cells and follicular dendritic cells, involved in the activation of B cells.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while CD10 is often associated with acute lymphoblastic leukemia (ALL), particularly the precursor B cell type, its expression is not limited to B cells and can be found on other cell types, making it less specific as a B cell marker compared to CD19 or CD20.

## **Correct Answer:** . CD10